Nexpoint Asset Management’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
ACM
Nexpoint Asset Management's AMYT Position: Q4 2022 in Review
Nexpoint Asset Management sold out of Amryt Pharma (AMYT) in Q4 2022, closing a stake of 40,000 shares — an estimated $277K sold.
Nexpoint Asset Management first reported a position in AMYT in Q4 2020 and held it in 8 quarters. The position peaked at $1.13M in Q4 2020. 58 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.
- Nexpoint Asset Management reported no remaining Amryt Pharma position as of Q4 2022 after selling out during the quarter.
- Nexpoint Asset Management sold 40,000 Amryt Pharma shares in Q4 2022, an estimated $277K.
- Nexpoint Asset Management first reported a position in Amryt Pharma in Q4 2020 and held it in 8 quarters.
- Nexpoint Asset Management's Amryt Pharma position peaked at $1.13M in Q4 2020.
- 58 funds tracked by Wall St. Rank held Amryt Pharma as of Q4 2022.
Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.